CAT

880.24

+1.69%↑

301.79

+0.28%↑

GEV.US

1,039.26

-0.58%↓

RTX

176.91

+0.22%↑

218.99

-0.21%↓

CAT

880.24

+1.69%↑

301.79

+0.28%↑

GEV.US

1,039.26

-0.58%↓

RTX

176.91

+0.22%↑

218.99

-0.21%↓

CAT

880.24

+1.69%↑

301.79

+0.28%↑

GEV.US

1,039.26

-0.58%↓

RTX

176.91

+0.22%↑

218.99

-0.21%↓

CAT

880.24

+1.69%↑

301.79

+0.28%↑

GEV.US

1,039.26

-0.58%↓

RTX

176.91

+0.22%↑

218.99

-0.21%↓

CAT

880.24

+1.69%↑

301.79

+0.28%↑

GEV.US

1,039.26

-0.58%↓

RTX

176.91

+0.22%↑

218.99

-0.21%↓

Home・Aktien・CryoPort Inc

CryoPort Inc

Geschlossen

BrancheIndustrie

14 -1.48

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.88

Max

14.03

Schlüsselkennzahlen
By Trading Economics
Einkommen	14M -9.4M
Verkäufe	2.3M 48M
EPS	-0.189
Gewinnspanne	-19.733
Angestellte	684
EBITDA	443K -3.2M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+0.5% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	4. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	150M 671M
Vorheriger Eröffnungskurs	15.48
Vorheriger Schlusskurs	14

Nachrichtenstimmung

By Acuity

41%

59%

141 / 404 Ranking in Industrials

CryoPort Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

CryoPort Inc Prognose

Kursziel

By TipRanks

0.5% Vorteil

12-Monats-Prognose

Durchschnitt 14.07 USD 0.5%

Hoch 17 USD

Tief 9.5 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für CryoPort Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

Buy

Halten

Sell

Basierend auf 8 Analysten, die in den letzten 3 Monaten Aktienbewertungen für CryoPort Inc – Dist abgegeben haben.

Stimmung

By Acuity

141 / 404 Ranking in Industrie

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.